Back to results

Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centro di Riferimento Oncologico IRCCS

Aviano, Italy

+23 additional locations

Contact

Claudio Vernieri, M.D., Ph.D.

+390223903066 claudio.vernieri@istitutotumori.mi.it

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2023-05-01
Enrollment: 3,500 participants
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Locations (24)

Centro di Riferimento Oncologico IRCCSAviano, Italy
Azienda Socio Sanitaria Territoriale degli Spedali CiviliBrescia, Italy
Humanitas Istituto Clinico CataneseCatania, Italy
ASST Lariana - Ospedale Sant'AnnaComo, Italy
ASST Ospedale MaggioreCremona, Italy
Azienda Ospedaliero Universitaria CareggiFlorence, Italy
Ospedale San MartinoGenova, Italy
Istituto Tumori della Romagna IRST IRCCSMeldola, Italy
Fondazione IRCCS Ca' Granda Ospedale MaggioreMilan, Italy
IEO Istituto Europeo di OncologiaMilan, Italy
IRCCS Ospedale San RaffaeleMilan, Italy
Ospedale ASST Fatebenefratelli SaccoMilan, Italy
ULSS 3 VenetoMirano, Italy
Azienda Ospedaliero-UniversitariaModena, Italy
Azienda Ospedaliero-Universitaria Federico IINaples, Italy
Istituto Nazionale Tumori IRCCS Fondazione G. PascaleNaples, Italy
Ospedale Maggiore della CaritàNovara, Italy
IOV Istituto Oncologico Veneto IRCCSPadova, Italy
Fondazione IRCCS Policlinico San MatteoPavia, Italy
IRCCS - ICS MaugeriPavia, Italy
Clinica Ospedaliero - Universitaria Policlinico Umberto IRoma, Italy
Policlinico Universitario Campus Bio-MedicoRoma, Italy
Policlinico Universitario Fondazione Agostino GemelliRoma, Italy
Istituto Clinico HumanitasRozzano, Italy

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study — TrialFind